Justice Dept. Civil Fraud Recoveries Total $2.1 Billion for FY 2003; False Claims Act Recoveries Exceed $12 Billion Since 1986 (03-613)

DOJ press release 03-613 (10 Nov 2003): record $2.1 billion recoveries in FY2003, 75% above FY2002 ($1.1 billion), over $12 billion since 1986; $1.48 billion from qui tam suits; relator share rules (15-25% with intervention, up to 30% without); over $319 million in rewards; health care $1.7 billion; defence procurement $299 million; Interior gas leases $49 million; largest recoveries: HCA $641 million (HCA total $1.7 billion, whistleblowers $154 million), Abbott $382 million (undercover Operation Headwaters; states $18 million + $14.5 million; $200 million criminal fines), AstraZeneca $280 million (whistleblower $47.7 million), Northrop Grumman $191 million ($111 million TRW, whistleblower $27.2 million; $60 million; $20 million), Bayer $143 million (whistleblower allegations; $108 million to states), GlaxoSmithKline $47 million (+$40 million), Tenet $51 million (+ nearly $3 million), Endovascular $49 million (+$43.4 million criminal), Shell $49 million (earlier $56 million and $110 million), Lockheed Martin $38 million. Already in the data: 7 observations and the HCA case. Added: 3 rules, Interior gas-lease recoveries, 3 whistleblower cases (AstraZeneca, Northrop/TRW, Bayer). Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 8 cases (8 settlements). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Abbott is recorded with a note that the release attributes it to a government undercover operation. The existing HCA case ($1.7 billion total) covers the $641 million FY2003 settlement and was not repeated.